Though more work needs to be done to elaborate the mechanism underlying VEGFR2 activation in the absence of CCM proteins, our work supports the potential impact of VEGF signalling induced by infection as an important disease modifier and opportunity for therapeutic intervention. This evidence concerns the gene VEGFA and infection.